What do monoamines do in pain modulation?
What do monoamines do in pain modulation?
复制标题
DOI:
10.1097/spc.0000000000000207
复制
发表时间:
2016-06
影响因子:
2.1
通讯作者:
Dickenson AH
中科院分区:
文献类型:
--
作者:
Bannister K;Dickenson AH
Here we give a topical overview of the ways in which brain processing can alter spinal pain transmission through descending control pathways, and how these change in pain states. We link preclinical findings on the transmitter systems involved and discuss how the monoamines, noradrenaline (NA), 5-hydroxytryptamine (5-HT) and dopamine, can interact through inhibitory and excitatory pathways. Descending pathways control sensory events and the actions of the neurotransmitters NA and 5-HT in the dorsal horn of the spinal cord are chiefly implicated in nociception or anti-nociception according to the receptor that is activated. Abnormalities in descending controls effect central pain processing. Following nerve injury a NA-mediated control of spinal excitability is lost while its restoration reduces neuropathic hypersensitivity. The story with 5-HT remains more complex due to the myriad of receptors that it can act upon; however the most recent findings support that facilitations may dominate over inhibitions. The monoaminergic system can be manipulated to great effect in the clinic resulting in improved treatment outcomes and is the basis for the actions of the anti-depressant drugs in pain. Looking to the future, prediction of treatment responses will possible by monitoring a form of inhibitory descending control for optimised pain-relief.